Skip to Content Skip to Search
Handshake
Building trust

Investors

GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical and vaccine products.

As a listed entity, we have a responsibility to communicate our strategy and performance to investors in order to promote confidence. Information for investors includes share information, share analysis, shareholder news and annual reports.

Key information

Stock Exchange Symbol

GLAXO

Compliance Certificate

GSK Pakistan's Compliance CertificatePDF - 266.1KB

Corporate Briefing Session GSK Pakistan

Corporate Briefing Session Letter 2022PDF - 588.9KB Corporate Briefing Presentation 2022PDF - 2.0MB Corporate Briefing Session 2022 AudioMP3 - 12.5MB

For complaints or queries please contact:

Ms. Mehar-e-daraksha Ameer
Legal Director/Company Secretary

Email: PK.Shareinfo@gsk.com
Phone No: +9221 111 475 725

Erum Shakir Rahim CEO - GSK

Erum Shakir Rahim CEO - GSK

Reflections on 2021 performance

Source- IQVIA: MAT Dec '21

Financial Highlights

Key operation and financial data

Financial Highlights 2021 PDF - 134.9KB

DISCLAIMER: “In case your complaint has not been properly redressed by us, you may lodge your complaint with Securities and Exchange Commission of Pakistan (the “SECP”). However, please note that SECP will entertain only those complaints which were at first directly requested to be redressed by the Company and the company has failed to redress the same. Further, the complaints that are not relevant to SECP’s regulatory domain/competence shall not be entertained.”

Find out more